Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jack Fowler

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
Acta Oncologica (Stockholm, Sweden)|September 20, 2006
Accreditation and quality assurance for Radiation Therapy Oncology Group: Multicenter clinical trials using Stereotactic Body Radiation Therapy in lung cancerRobert Timmerman, James Galvin, Jeff Michalski, et al.
International Journal of Radiation Oncology, Biology, Physics|January 6, 2010
A prospective phase III randomized trial of hypofractionation versus conventional fractionation in patients with high-risk prostate cancerGiorgio Arcangeli, Biancamaria Saracino, Sara Gomellini, et al.
Medical Physics|November 11, 2005
Feasibility study of helical tomotherapy for total body or total marrow irradiationSusanta K Hui, Jeff Kapatoes, Jack Fowler, et al.
Annals of Surgical Oncology|March 30, 2002
An experimental evaluation of three preoperative radiation regimens for resectable rectal cancerGenc Basha, Willy Landuyt, Jack Fowler, et al.
Clinical Lung Cancer|September 24, 2005
Potential for radiation therapy technology innovations to permit dose escalation for non-small-cell lung cancerRafael R Manon, Hazim Jaradat, Rakesh Patel, et al.
International Journal of Radiation Oncology, Biology, Physics|September 22, 2009
Spinal cord tolerance for stereotactic body radiotherapyArjun Sahgal, Lijun Ma, Iris Gibbs, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 7, 2010
Primary analysis of the phase II component of a phase I/II dose intensification study using three-dimensional conformal radiation therapy and concurrent chemotherapy for patients with inoperable non-small-cell lung cancer: RTOG 0117Jeffrey D Bradley, Kyounghwa Bae, Mary V Graham, et al.
International Journal of Radiation Oncology, Biology, Physics|May 12, 2010
A phase I/II radiation dose escalation study with concurrent chemotherapy for patients with inoperable stages I to III non-small-cell lung cancer: phase I results of RTOG 0117Jeffrey D Bradley, Jennifer Moughan, Mary V Graham, et al.
Acta Oncologica (Stockholm, Sweden)|October 6, 2007
Clinical outcome in patients with prostate cancer treated with external beam radiotherapy and high dose-rate iridium 192 brachytherapy boost: a 6-year follow-upKarl Mikael Kälkner, Thomas Wahlgren, Marianne Ryberg, et al.
JAMA|March 18, 2010
Stereotactic body radiation therapy for inoperable early stage lung cancerRobert Timmerman, Rebecca Paulus, James Galvin, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Acta Oncologica (Stockholm, Sweden)|September 20, 2006
Accreditation and quality assurance for Radiation Therapy Oncology Group: Multicenter clinical trials using Stereotactic Body Radiation Therapy in lung cancerRobert Timmerman, James Galvin, Jeff Michalski, et al.
International Journal of Radiation Oncology, Biology, Physics|January 6, 2010
A prospective phase III randomized trial of hypofractionation versus conventional fractionation in patients with high-risk prostate cancerGiorgio Arcangeli, Biancamaria Saracino, Sara Gomellini, et al.
Medical Physics|November 11, 2005
Feasibility study of helical tomotherapy for total body or total marrow irradiationSusanta K Hui, Jeff Kapatoes, Jack Fowler, et al.
Annals of Surgical Oncology|March 30, 2002
An experimental evaluation of three preoperative radiation regimens for resectable rectal cancerGenc Basha, Willy Landuyt, Jack Fowler, et al.
Clinical Lung Cancer|September 24, 2005
Potential for radiation therapy technology innovations to permit dose escalation for non-small-cell lung cancerRafael R Manon, Hazim Jaradat, Rakesh Patel, et al.
International Journal of Radiation Oncology, Biology, Physics|September 22, 2009
Spinal cord tolerance for stereotactic body radiotherapyArjun Sahgal, Lijun Ma, Iris Gibbs, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 7, 2010
Primary analysis of the phase II component of a phase I/II dose intensification study using three-dimensional conformal radiation therapy and concurrent chemotherapy for patients with inoperable non-small-cell lung cancer: RTOG 0117Jeffrey D Bradley, Kyounghwa Bae, Mary V Graham, et al.
International Journal of Radiation Oncology, Biology, Physics|May 12, 2010
A phase I/II radiation dose escalation study with concurrent chemotherapy for patients with inoperable stages I to III non-small-cell lung cancer: phase I results of RTOG 0117Jeffrey D Bradley, Jennifer Moughan, Mary V Graham, et al.
Acta Oncologica (Stockholm, Sweden)|October 6, 2007
Clinical outcome in patients with prostate cancer treated with external beam radiotherapy and high dose-rate iridium 192 brachytherapy boost: a 6-year follow-upKarl Mikael Kälkner, Thomas Wahlgren, Marianne Ryberg, et al.
JAMA|March 18, 2010
Stereotactic body radiation therapy for inoperable early stage lung cancerRobert Timmerman, Rebecca Paulus, James Galvin, et al.
Pageof 4